Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
29.7M
-
Shares change
-
-922K
-
Total reported value, excl. options
-
$141M
-
Value change
-
-$4.44M
-
Put/Call ratio
-
0.06
-
Number of buys
-
41
-
Number of sells
-
-17
-
Price
-
$4.76
Significant Holders of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) as of Q1 2025
82 filings reported holding ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value as of Q1 2025.
ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.7M shares
of 51.9M outstanding shares and own 57.17% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (3.69M shares), Nantahala Capital Management, LLC (3.51M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.69M shares), Western Standard LLC (2.28M shares), VANGUARD GROUP INC (2.02M shares), Vivo Capital, LLC (1.84M shares), Rosalind Advisors, Inc. (1.81M shares), Laurion Capital Management LP (1.31M shares), MILLENNIUM MANAGEMENT LLC (810K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (761K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.